Literature DB >> 2461164

Selective imipenem resistance in Pseudomonas aeruginosa associated with diminished outer membrane permeability.

A E Studemeister1, J P Quinn.   

Abstract

The permeability of the outer membranes of imipenem-susceptible and imipenem-resistant clinical isolates of Pseudomonas aeruginosa was investigated by the liposome swelling assay. Sugars and cephaloridine penetrated rapidly, whereas imipenem penetrated poorly into liposomes constructed from porin-rich outer membrane fractions of the resistant isolates.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2461164      PMCID： PMC172390          DOI： 10.1128/AAC.32.8.1267

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

Review 1.  Role of permeability barriers in resistance to beta-lactam antibiotics.

Authors:  H Nikaido
Journal:  Pharmacol Ther       Date:  1985       Impact factor: 12.310

2.  Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.

Authors:  J P Quinn; E J Dudek; C A DiVincenzo; D A Lucks; S A Lerner
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

3.  Emergence of resistance to imipenem in Pseudomonas aeruginosa.

Authors:  M J Lynch; G L Drusano; H L Mobley
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

4.  Porin channels in Escherichia coli: studies with liposomes reconstituted from purified proteins.

Authors:  H Nikaido; E Y Rosenberg
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

5.  Expression in Escherichia coli and function of Pseudomonas aeruginosa outer membrane porin protein F.

Authors:  W A Woodruff; T R Parr; R E Hancock; L F Hanne; T I Nicas; B H Iglewski
Journal:  J Bacteriol       Date:  1986-08       Impact factor: 3.490

6.  Outer membrane of Pseudomonas aeruginosa: heat- 2-mercaptoethanol-modifiable proteins.

Authors:  R E Hancock; A M Carey
Journal:  J Bacteriol       Date:  1979-12       Impact factor: 3.490

7.  Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

8.  Pseudomonas aeruginosa outer membrane permeability: isolation of a porin protein F-deficient mutant.

Authors:  T I Nicas; R E Hancock
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

9.  Imipenem/cilastatin in acute pulmonary exacerbations of cystic fibrosis.

Authors:  L R Krilov; J L Blumer; R C Stern; A I Hartstein; B N Iglewski; D A Goldmann
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug

10.  Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections.

Authors:  D J Winston; M A McGrattan; R W Busuttil
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191
View more
  9 in total

1.  Decreased outer membrane permeability in imipenem-resistant mutants of Pseudomonas aeruginosa.

Authors:  J Trias; J Dufresne; R C Levesque; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

2.  New norfloxacin resistance gene in Pseudomonas aeruginosa PAO.

Authors:  H Fukuda; M Hosaka; K Hirai; S Iyobe
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

3.  Diffusion of beta-lactam antibiotics through liposome membranes reconstituted from purified porins of the outer membrane of Pseudomonas aeruginosa.

Authors:  S Satake; E Yoshihara; T Nakae
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

4.  Imipenem resistance in pseudomonas aeruginosa PAO: mapping of the OprD2 gene.

Authors:  J P Quinn; A Darzins; D Miyashiro; S Ripp; R V Miller
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

5.  Increase in susceptibility of Pseudomonas aeruginosa to carbapenem antibiotics in low-amino-acid media.

Authors:  T Fukuoka; N Masuda; T Takenouchi; N Sekine; M Iijima; S Ohya
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

Review 6.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

7.  Mechanism of enhanced antipseudomonal activity of BO-2727, a new injectable 1-beta-methyl carbapenem.

Authors:  N Hazumi; A Fuse; K Matsuda; T Hashizume; M Sanada
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

Review 8.  Pseudomonas aeruginosa resistance phenotypes and phenotypic highlighting methods.

Authors:  Maria Bălăşoiu; A T Bălăşoiu; Rodica Mănescu; Carmen Avramescu; Oana Ionete
Journal:  Curr Health Sci J       Date:  2014-03-29

9.  Whole Genome Multi-Locus Sequence Typing and Genomic Single Nucleotide Polymorphism Analysis for Epidemiological Typing of Pseudomonas aeruginosa From Indonesian Intensive Care Units.

Authors:  Manisha Goyal; Andreu Coello Pelegrin; Magali Jaillard; Yulia Rosa Saharman; Corné H W Klaassen; Henri A Verbrugh; Juliëtte A Severin; Alex van Belkum
Journal:  Front Microbiol       Date:  2022-07-14       Impact factor: 6.064
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.